(grouped together into the 0-14 year age group) are specifi cally identifi ed in the NTP's quarterly reports. At the General Hospital (GH) in Cotonou, the economic capital, children are diagnosed and treated on the basis of information recorded in their personal medical fi les, but are never notifi ed to the NTP, for a variety of reasons. NTP data on children are therefore incomplete and cannot be used to estimate the true burden of childhood disease in Benin.
Setting
Benin is a small country in West Africa with a population of 9 million and a gross national income of US$780 per capita (http://data.worldbank.org/about/countryclassifi cations). The NTP notifi es about 3500 TB cases each year. The national incidence rate of notifi ed new TB cases has been stable over the last 10 years, at 41-46 per 100 000 population. The NTP follows the DOTS strategy and uses internationally recognised criteria for diagnosing and treating patients with TB. 6, 7 The NTP has a central unit responsible for policy and strategy, while diagnosis, registration and care are decentralised to 57 public or private basic management units (BMUs) in the country.
The present study was conducted in Cotonou and its suburbs, which has a population of about 1 million. There are fi ve BMUs in Cotonou, all of which have a TB register and use TB treatment cards. The GH has a G lobally, childhood tuberculosis (TB) has received limited priority in National TB Programmes (NTPs) due to the fact that children tend to be smearnegative and are therefore perceived to have limited infectiousness; also, numbers are often thought to be few. 1 The numbers of children reported with TB may also be inaccurate due to diffi culties in diagnosing both pulmonary and extra-pulmonary TB.
Children aged <15 years constitute about 11% of the estimated 9 million TB cases worldwide, 2 and up to 15% in low-income countries. 3 Although this proportion may seem small, TB in children aged <5 years, particularly those aged <2 years, has been shown to cause high mortality and morbidity. 4 Globally, TB has been reported to be one of the most important causes of death among children, 2 and treatment outcomes among children with TB have also been found to be poor. 5 In Benin, information about the burden of TB in children is limited. While children with TB are registered and their outcomes are recorded in the NTP's TB register, only sputum smear-positive pulmonary cases paediatric department and a paediatric surgery department, where children are also diagnosed and treated for TB, but are not notifi ed to the NTP.
Diagnosis and treatment of tuberculosis
Children are suspected of TB if they have chronic symptoms such as cough for >3 weeks, persistent fever, malnutrition, weight loss and/or failure to thrive. The presence of an adult with sputum smear-positive TB living in the same household as the child may be an indication of TB due to contact with the index case. Child TB suspects are investigated using sputum smear microscopy, if they can produce sputum, or, if feasible, gastric lavage, chest radiography (interpreted by radiologists and chest physicians) and tuberculin skin testing. Mycobacterium tuberculosis culture from sputum or other specimens is occasionally performed. Lack of response to non-specifi c antibiotics may also indicate a diagnosis of TB. If the child's health status is poor, treatment is started immediately.
At both the NTP facilities and the GH, diagnosed children are classifi ed as pulmonary (smear-positive and smear-negative) and extra-pulmonary TB, and as new and previously treated cases, according to national and international guidelines. 6,7 All diagnosed children are supposed to be registered with a BMU close to their homes, and to receive standardised treatment. Children aged <8 years receive rifampicin (RMP), pyrazinamide and isoniazid (INH) for the 2-month initial phase, followed by RMP and INH for the 4-month continuation phase. Treatment for children aged ⩾8 years is similar, except that ethambutol is added to the initial phase to make a total of four drugs. At the GH in Cotonou, however, the anti-tuberculosis regimens used do not always follow these recommendations.
For diagnosis, less than US$1 is usually, but not necessarily, required as payment for sputum smear examination at both the GH and the NTP. Treatment is free, and anti-tuberculosis drugs are provided by the NTP (they are not available in private pharmacies). Treatment outcomes are monitored using treatment cards and paper registers at both the NTP and the GH, and NTP outcomes are reported in quarterly reports.
Healthy children aged <5 years and living in the same household as an adult with sputum smear-positive TB are given INH preventive therapy (IPT) for 9 months.
Patients
All children aged 0-14 years who were diagnosed and treated for TB in Cotonou and its suburbs between 1 January 2009 and 31 December 2011 were included in the study. Children who were receiving IPT were excluded.
Data collection
Sources of data were the NTP TB registers and the GH medical fi les. Diagnosis was made by general practitioners and chest physicians in the NTP and by paediatricians at the GH. Data from each individual patient were collected using a standardised paperbased study questionnaire. To avoid errors, each data variable was collected by two different investigators.
The following data were collected: epidemiological characteristics of the child (sex, age), type and category of TB, HIV status (positive, negative, indeterminate and unknown) and standardised treatment outcomes. For these variables, standardised defi nitions of the International Union Against Tuberculosis and Lung Disease (The Union) and the World Health Organization (WHO) were used by both the GH and the NTP. 8 If the treatment outcome was not known, it was classifi ed as 'unknown'. Treatment outcomes were 'successful' if the children were cured or had completed treatment, and 'unsuccessful' if the children died, were lost to follow-up, failed treatment, were transferred out or unknown. A child was classifi ed as 'still on treatment' if treatment had not yet been completed.
Statistical analysis
Data from the questionnaire were double-entered into EpiData version 3.1 (EpiData Association, Odense, Denmark). Using frequency analysis, demographic and clinical characteristics and site of diagnosis and care were analysed in relation to treatment outcomes using the χ 2 test, relative risks (RRs) and 95% confi dence intervals (95%CIs). Comparisons were made using Epi Info, version 6.04dfr (Centers for Disease Control and Prevention, Atlanta, GA, USA). Levels of signifi cance were set at 5%.
Ethics
The study was approved by the Ethics Advisory Group of The Union and the Ethics Committee of the Benin NTP.
RESULTS

Epidemiological characteristics
The number of children treated for TB, all forms, in Cotonou from 2009 to 2011 was 182 (67, 42 and 73 cases respectively in 2009, 2010 and 2011), representing 4.5% of all TB cases notifi ed annually ( Table 1 ). The male:female sex ratio was 0.94; 58 (32%) children were aged <5 years and 124 (68%) were aged between 5 and 14 years. The incidence rate of notifi ed TB cases among children in Cotonou was between 8 and 13/100 000, much lower than that observed among adults (P < 0.01). Reported cases were higher among children aged >5 years (Table 2) . One hundred and fi ftythree children (84%) were treated at NTP facilities, while 29 children (16%) were treated at the GH but were not notifi ed. Thus, during these 3 years, 16% of all TB cases diagnosed among children were omitted from national fi gures because they were not notifi ed to the NTP. Table 3 shows TB case notifi cations by place of treatment (NTP facilities, GH and all sites), stratifi ed by age, sex, type of TB and HIV status. Five times more patients were treated at the NTP facilities than at the GH, and signifi cantly more new sputum smear-positive pulmonary TB (PTB) patients were diagnosed at NTP facilities (P < 0.01), while signifi cantly more extra-pulmonary TB (EPTB) cases were diagnosed at the GH (P < 0.01). HIV status was known for 167 (92%) children, of whom 49 were positive (29%). Significantly more children in the GH did not have their HIV status assessed compared with NTP facilities (P < 0.01). Table 4 shows the number of children with different types of EPTB. There were 45 children with EPTB at one site alone, 34 with both PTB and EPTB (registered as PTB cases) and 3 children with 
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EPTB at two sites. The most common sites for EPTB were the lymph nodes, vertebrae and pleura.
Treatment outcomes
Of the 182 patients diagnosed, 163 had completed treatment and 19 were still on treatment at the time of data collection. Treatment outcomes, stratifi ed by place, age, sex, type of TB and HIV status, are shown in Table 5 . The cure rate was higher among children in the NTP facilities than among those from the GH (P < 0.01), where the rate of unknown outcome was higher. In comparing successful (cure and/or treatment completed) and unsuccessful (death, loss to follow-up and unknown) treatment outcomes between the different groups, successful treatment outcomes were lower in smear-negative than in smear-positive children (RR 0.72, 95%CI 0.58-0.90, P < 0.01), and in HIV-positive compared with HIV-negative children (RR 0.73, 95%CI 0.56-0.96, P < 0.01). All of the HIV-TB co-infected children were on cotrimoxazole preventive therapy. Information about antiretroviral treatment (ART) was not, however, collected during the study. In all other respects, there were no signifi cant differences between the groups.
DISCUSSION
The study is the fi rst in Benin to describe the burden of TB and treatment outcomes among children in Cotonou, and this in turn has a direct infl uence on results at a national level. Our main fi ndings were a treatment rate among children that was lower than WHO global estimates (4.5% vs. 11% of total cases) and a higher proportion of children treated in the age group 5-14 years than among younger children (68% vs. 32%). Approximately 16% of the children were diagnosed and treated at the GH and were not notifi ed, contributing to an underreporting of the true burden of (14) 2 (14) * Number of children who completed follow-up for treatment. TB = tuberculosis; HIV = human immunodeficiency virus; LTFU = loss to follow-up; NTP = National TB Control Programme; EPTB = extra-pulmonary TB. (24) 17 (21) 9 (11) 4 (5) 3 (4) 2 (2) 2 (2) 2 (2) 1 (1) 82 (100) Public Health Action TB children in Cotonou: burden and outcome 18 childhood TB in Cotonou and Benin. As a greater proportion of children at the GH were diagnosed with EPTB, this type of TB is particularly underreported. This may also be due to misdiagnosis due to lack of training in childhood TB among health care workers, as training in TB generally focuses on the detection of smearpositive TB in adults. Reports about TB prevalence being higher in younger children are confl icting. [9] [10] [11] [12] [13] [14] Although younger children are at greater risk of progressing to active TB once infected with M. tuberculosis, they were underrepresented in our study, possibly due to misdiagnosis. [15] [16] [17] [18] For example, TB in younger children presenting with acute pneumonia or malnutrition may be missed due to clinical overlap with other common child illnesses, and die due to TB. In addition, collecting adequate sputum specimens in this young age group is very diffi cult. Studies increasingly advocate the implementation of other sampling methods, such as induced sputum, in primary health care settings. 19, 20 This study was conducted in an urban setting, with a low rate of children being diagnosed and treated for TB. We assume that this rate is even lower in rural settings due to the shortage of specialists and diffi culty in accessing health care services.
The predominance of lymph node, pleural and spinal TB among EPTB patients (72%) is similar to that reported in Malawi (62%). 21 We found TB meningitis to be rare, however, in contrast to the higher rates reported elsewhere. 22 Reasons for this may include diffi culty in confi rming the diagnosis, and bacille Calmette-Guérin vaccination coverage of almost 100% in Benin, which protects children against severe forms of TB such as TB meningitis and miliary disease. 23, 24 It should be noted that although Benin is not a high-burden country for HIV (1.7%), HIV prevalence among children with TB was high (29%), and much higher than in adults (15%). A limitation of our study is that data on ART were not recorded. However, WHO recommendations for ART were applied on the whole. 25 The number of maternity wards involved in preventive motherto-children treatment is increasing (61% in 2012), and there is a transition to three-drug prophylaxis. However, full coverage of pregnant women has not yet been achieved (51% in 2010).
Treatment outcomes among the children were reasonable. The overall treatment success rate, at 72%, was higher than that reported in Malawi (45%), 21 but lower than in Djibouti in 2010 (84%). 26 A higher treatment success rate of 86% in smear-positive cases was close to that reported for adults (90%); 2 overall better treatment outcomes could be obtained through better monitoring systems to reduce loss to follow-up and unknown outcomes, and possibly by more accurate diagnosis. For example, unknown outcomes were particularly common in children registered and treated at the GH. This may be related to misdiagnosis (with consequent discontinuation) or lack of information on treatment duration. Referring children to BMUs (where health care workers trace all patients lost to follow-up) for their treatment monitoring may be one solution. Appointments would also be set with the GH practitioner. Unsurprisingly, worse outcomes were observed in smearnegative and HIV-infected children, as the TB diagnosis in both cases was doubtful.
In conclusion, childhood TB makes up a small proportion of all reported TB cases in Cotonou, Benin. While treatment outcomes are reasonable, particularly for smear-positive cases, better follow-up and monitoring is needed during treatment to reduce the high burden of loss to follow-up and unknown outcomes.
Greater collaboration between the NTP and the General Hospital is required to improve case notifi cation and treatment outcomes, and we have been working to address these issues since the completion of the study. On a noté des taux moins bons de succès du traitement chez les enfants atteints de TB à bacilloscopie négative (62%) et chez les enfants atteints d'une infection par le VIH (58%). Conclusion : Le nombre d'enfants traités pour TB est faible. Les carences de diagnostic portent principalement chez les enfants plus jeunes. Il est nécessaire d'améliorer à la fois le diagnostic de la TB infantile, particulièrement parmi les enfants plus jeunes, ainsi que les résultats du traitement chez les enfants co-infectés par le TB-VIH, en améliorant le suivi et la surveillance de ces patients.
Contexte
Marco de referencia:
Los centros del Programa Nacional contra la Tuberculosis (PNT) y los servicios de pediatría en el Hospital General (GH) de Cotonou, en Benin. Objetivos: Describir la carga de morbilidad por tuberculosis (TB), las características de los niños tratados en Cotonou y los desenlaces clí-nicos de la enfermedad entre el 2009 y el 2011. Métodos: Fue este un estudio de cohortes transversal de todos los niños con diagnóstico de TB <15 años de edad, basado en la análisis retrospectivo de archivos. Resultados: Entre el 2009 y el 2011 se diagnosticaron 182 niños con TB (4,5% de todos los casos): 153 en los establecimientos del PNT (84%) y 29 (16%) en el GH que no se notificaron al PNT. La tasa de incidencia de casos notificados osciló entre 8 y 13 en 100 000 y fue más alta en los niños >5 años de edad. El 29% de los 167 niños con prueba diagnóstica del virus de la inmunodeficiencia humana (VIH) obtuvo un resultado positivo. La tasa global de tratamiento exitoso fue 72%, en los casos con baciloscopia positiva fue 86%, en los casos con baciloscopia negativa fue 62% y 74% de los niños con diagnó-stico de TB extrapulmonar alcanzaron un desenlace favorable. Las t asas más bajas de éxito terapéutico se observaron en los niños con TB baciloscopia negativa (62%) y en los niños que sufrían coinfección por el VIH (58%). Conclusión: La cantidad de niños tratados por TB es baja en este entorno. El diagnóstico se pasa por alto sobre todo en los niños de más corta edad. Es preciso mejorar el diagnóstico y el desenlace terapéu-tico de la TB en la infancia, mediante una mayor atención al tratamiento de la infección por el VIH y un mejor seguimiento.
